Search results for "From Annals of Internal Medicine"
California's insulin plan, clinical decision support in lower-income countries
Recent articles from Annals of Internal Medicine discussed California's plan to produce insulin and a diabetes clinical decision support system that may be helpful in primary care in low- to middle-income countries.
https://diabetes.acponline.org/archives/2022/12/09/8.htm
9 Dec 2022
Recent WHO diabetes guideline summarized and critiqued
The updated guideline from the World Health Organization (WHO) included five recommendations, some of which differed from ACP's most recent diabetes guideline.
https://diabetes.acponline.org/archives/2018/09/14/6.htm
14 Sep 2018
Crowdfunding campaigns often focus on overall cost of diabetes, rarely mention insulin
A quarter of fundraisers for patients with diabetes reported that the patient had insurance, and many mentioned noncovered costs such as lost wages, healthy food, and diabetic alert dogs.
https://diabetes.acponline.org/archives/2023/07/14/6.htm
14 Jul 2023
Recent KDIGO guideline focused on patients with diabetes and kidney disease
A new summary of the guideline from Kidney Disease: Improving Global Outcomes (KDIGO) highlights important points for clinicians, including recommendations about prescribing of diabetes medications.
https://diabetes.acponline.org/archives/2020/11/13/7.htm
13 Nov 2020
In the Clinic: Type 2 Diabetes
Current evidence on prevention and treatment of type 2 diabetes is summarized in a new In the Clinic article targeted at primary care physicians.
https://diabetes.acponline.org/archives/2019/11/08/6.htm
8 Nov 2019
Low-carb diet improved diabetes control, but effects didn't last
Patients with type 2 diabetes randomized to a low-carb, high-fat diet for six months showed more improvement in HbA1c level than those assigned to a low-fat, high-carb diet, a Danish trial found.
https://diabetes.acponline.org/archives/2023/01/13/6.htm
13 Jan 2023
ACP Journal Club: SGLT-2 inhibitors reduce adverse renal and CV outcomes in patients with or without diabetes
The results of this meta-analysis of sodium-glucose cotransporter-2 (SGLT-2) inhibitors highlight the opportunity for internists, nephrologists, endocrinologists, and cardiologists to collaborate to expand use of the drug class, an ACP Journal Club commentary said.
https://diabetes.acponline.org/archives/2023/03/10/7.htm
10 Mar 2023
Recent articles address federal diabetes programs, type 1 diabetes care
The National Clinical Care Commission made 39 recommendations for improving federal diabetes programs, and the latest In the Clinic article offered advice on diagnosing and treating type 1 diabetes.
https://diabetes.acponline.org/archives/2022/03/11/6.htm
11 Mar 2022
Improvement in polymyalgia rheumatica associated with improved control of diabetes
A three-case series suggests that tighter glycemic control might allow some patients with type 2 diabetes to avoid glucocorticoid treatment for polymyalgia rheumatica.
https://diabetes.acponline.org/archives/2020/10/09/7.htm
9 Oct 2020
In patients with type 2 diabetes and CKD, finerenone improved CV and kidney outcomes
An analysis of recent manufacturer-sponsored studies of finerenone show it to be a potentially important new treatment for patients with type 2 diabetes and albuminuric chronic kidney disease (CKD), although it poses risk for serious hyperkalemia, an ACP Journal Club commentary said.
https://diabetes.acponline.org/archives/2022/05/13/6.htm
13 May 2022